Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 27, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/20/2679    most recent
ddg294v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (81)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Haiman, C. A.
Right arrow Articles by Henderson, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haiman, C. A.
Right arrow Articles by Henderson, B. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 20 2679-2692
DOI: 10.1093/hmg/ddg294
© 2003 Oxford University Press

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort

Christopher A. Haiman1,*, Daniel O. Stram1, Malcolm C. Pike1, Laurence N. Kolonel2, Noel P. Burtt3, David Altshuler3,4,5,6, Joel Hirschhorn3,6,7 and Brian E. Henderson1

1Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA, 2Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813, USA, 3Whitehead/MIT Center for Genome Research, Cambridge, MA 02139, USA, 4Department of Medicine, Harvard Medical School, Boston, MA 02115, USA, 5Department of Molecular Biology and Diabetes Unit, Massachusetts General Hospital, Boston, MA 02114, USA, 6Department of Genetics, Harvard Medical School, Boston, MA 02115, USA and 7Division of Endocrinology, Children's Hospital and Department of Pediatrics, Boston, MA 02115, USA

Received June 18, 2003; Accepted August 16, 2003

The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the final step of estrogen biosynthesis. Apart from rare mutations in CYP19 which result in severe phenotypes associated with estrogen insufficiency, little is known about whether common variation in CYP19 is associated with risk of hormone-related diseases. In this study, we employed a haplotype-based approach to search for common disease-associated variants in this candidate breast cancer susceptibility gene among African-American, Hawaiian, Japanese, Latina and White women in the Multiethnic Cohort Study (MEC). We utilized 74 densely spaced single-nucleotide polymorphisms (SNPs) (one every ~2.6 kb) spanning 189.4 kb of the CYP19 locus to characterize linkage disequilibrium (LD) and haplotype patterns among 69–70 individuals from each ethnic population. We detected four regions of strong LD (blocks 1–4) that were quite closely conserved across populations. Within each block there was a limited diversity of common haplotypes (5 to 10 with a frequency >=5%) and most haplotypes were observed to be shared across populations. Twenty-five haplotype-tagging SNPs (htSNPs) were selected to predict the common haplotypes with high probability (average Rh2=0.92) and genotyped in a breast cancer case–control study in the MEC (cases, n=1355; controls, n=2580). We first performed global tests for differences in risk according to the common haplotypes and observed significant haplotype-effects in block 2 [P=0.01; haplotypes 2b (OR=1.23; 95% CI, 1.07–1.40), 2d (OR=1.28; 95% CI, 1.01–1.62)]. We also found a common long-range haplotype comprised of block-specific haplotypes 2b and 3c to be associated with increased risk of breast cancer (haplotype 2b–3c: OR=1.31; 95% CI, 1.11–1.54). Our findings suggest the hypothesis that women with the long-range CYP19 haplotype 2b–3c may be carriers of a predisposing breast cancer susceptibility allele.

* To whom correspondence should be addressed at: Department of Preventive Medicine, University of Southern California, USC/Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Rm 4441, Los Angeles, CA 90089-9175, USA. Tel: +1 3238650429; Fax: +1 3238650127; Email: haiman{at}usc.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
K.-D. Yu, G.-H. Di, W.-T. Yuan, L. Fan, J. Wu, Z. Hu, Z.-Z. Shen, Y. Zheng, W. Huang, and Z.-M. Shao
Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53
Hum. Mol. Genet., July 1, 2009; 18(13): 2502 - 2517.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Cheng, D. O. Stram, N. P. Burtt, L. Gianniny, R. R. Garcia, L. Pooler, B. E. Henderson, L. Le Marchand, and C. A. Haiman
IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1922 - 1924.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Raskin, F. Lejbkowicz, O. Barnett-Griness, S. Dishon, R. Almog, and G. Rennert
BRCA1 Breast Cancer Risk Is Modified by CYP19 Polymorphisms in Ashkenazi Jews
Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1617 - 1623.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, J. A. Doherty, X.-o. Shu, M. R. Akbari, C. Chen, I. De Vivo, A. DeMichele, M. Garcia-Closas, M. T. Goodman, C. A. Haiman, et al.
Two Estrogen-Related Variants in CYP19A1 and Endometrial Cancer Risk: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium
Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chen, L. C. Sakoda, J. A. Doherty, M. M. Loomis, S. Fish, R. M. Ray, M. G. Lin, W. Fan, L. P. Zhao, D. L. Gao, et al.
Genetic Variation in CYP19A1 and Risk of Breast Cancer and Fibrocystic Breast Conditions among Women in Shanghai, China
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3457 - 3466.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M. T Goodman, G. Lurie, P. J Thompson, K. E McDuffie, and M. E Carney
Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk
Endocr. Relat. Cancer, December 1, 2008; 15(4): 1055 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. V. Conti, W. Lee, D. Li, J. Liu, D. Van Den Berg, P. D. Thomas, A. W. Bergen, G. E. Swan, R. F. Tyndale, N. L. Benowitz, et al.
Nicotinic acetylcholine receptor {beta}2 subunit gene implicated in a systems-based candidate gene study of smoking cessation
Hum. Mol. Genet., September 15, 2008; 17(18): 2834 - 2848.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C.-S. Huang, S.-H. Kuo, H.-C. Lien, S.-Y. Yang, S.-L. You, C.-Y. Shen, C.-H. Lin, Y.-S. Lu, and K.-J. Chang
The CYP19 TTTA Repeat Polymorphism Is Related to the Prognosis of Premenopausal Stage I-II and Operable Stage III Breast Cancers
Oncologist, July 1, 2008; 13(7): 751 - 760.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. S. Saltzman, J. F. Yamamoto, R. Decker, L. Yokochi, A. G. Theriault, T. M. Vogt, and L. Le Marchand
Association of Genetic Variation in the Transforming Growth Factor {beta}-1 Gene with Serum Levels and Risk of Colorectal Neoplasia
Cancer Res., February 15, 2008; 68(4): 1236 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Colomer, M. Monzo, I. Tusquets, J. Rifa, J. M. Baena, A. Barnadas, L. Calvo, F. Carabantes, C. Crespo, M. Munoz, et al.
A Single-Nucleotide Polymorphism in the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor Letrozole in Advanced Breast Carcinoma
Clin. Cancer Res., February 1, 2008; 14(3): 811 - 816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Q. Cai, N. Kataoka, C. Li, W. Wen, J. R. Smith, Y.-T. Gao, X. O. Shu, and W. Zheng
Haplotype Analyses of CYP19A1 Gene Variants and Breast Cancer Risk: Results from the Shanghai Breast Cancer Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 27 - 32.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, G. Ursin, P. L. Horn-Ross, D. Van Den Berg, L. Le Marchand, B. E. Henderson, L. Bernstein, and C. A. Haiman
Germ Line Variation at 8q24 and Endometrial Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2166 - 2168.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Rohrmann, W. G. Nelson, N. Rifai, T. R. Brown, A. Dobs, N. Kanarek, J. D. Yager, and E. A. Platz
Serum Estrogen, But Not Testosterone, Levels Differ between Black and White Men in a Nationally Representative Sample of Americans
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2519 - 2525.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. H. Tao, Q. Cai, Z.-F. Zhang, W.-H. Xu, N. Kataoka, W. Wen, Y.-B. Xiang, W. Zheng, and X. O. Shu
Polymorphisms in the CYP19A1 (Aromatase) Gene and Endometrial Cancer Risk in Chinese Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 943 - 949.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Haiman, V. W. Setiawan, L. Y. Xia, L. Le Marchand, S. A. Ingles, G. Ursin, M. F. Press, L. Bernstein, E. M. John, and B. E. Henderson
A Variant in the Cytochrome P450 Oxidoreductase Gene Is Associated with Breast Cancer Risk in African Americans
Cancer Res., April 15, 2007; 67(8): 3565 - 3568.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Slattery, K. Curtin, R. Baumgartner, C. Sweeney, T. Byers, A. R. Giuliano, K. B. Baumgartner, and R. R. Wolff
IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 747 - 755.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Haiman, L. Dossus, V. W. Setiawan, D. O. Stram, A. M. Dunning, G. Thomas, M. J. Thun, D. Albanes, D. Altshuler, E. Ardanaz, et al.
Genetic Variation at the CYP19A1 Locus Predicts Circulating Estrogen Levels but not Breast Cancer Risk in Postmenopausal Women
Cancer Res., March 1, 2007; 67(5): 1893 - 1897.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. H. Olson, E. V. Bandera, and I. Orlow
Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE Review
Am. J. Epidemiol., February 1, 2007; 165(3): 235 - 245.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. D. McKay, R. Kaaks, M. Johansson, C. Biessy, F. Wiklund, K. Balter, H.-O. Adami, C. Boillot, L. Gioia-Patricola, F. Canzian, et al.
Haplotype-Based Analysis of Common Variation in the Growth Hormone Receptor Gene and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 169 - 173.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. W. Setiawan, I. Cheng, D. O. Stram, E. Giorgi, M. C. Pike, D. Van Den Berg, L. Pooler, N. P. Burtt, L. Le Marchand, D. Altshuler, et al.
A Systematic Assessment of Common Genetic Variation in CYP11A and Risk of Breast Cancer
Cancer Res., December 15, 2006; 66(24): 12019 - 12025.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Sun, Y. Gao, W. Tan, S. Ma, X. Zhang, Y. Wang, Q. Zhang, Y. Guo, D. Zhao, C. Zeng, et al.
Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression
Clin. Cancer Res., December 1, 2006; 12(23): 7009 - 7017.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J.-R. Long, N. Kataoka, X.-O. Shu, W. Wen, Y.-T. Gao, Q. Cai, and W. Zheng
Genetic Polymorphisms of the CYP19A1 Gene and Breast Cancer Survival.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Lu, Q. Wei, M. L. Bondy, D. Li, A. Brewster, S. Shete, T.-K. Yu, A. Sahin, F. Meric-Bernstam, K. K. Hunt, et al.
Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <=55 years
Carcinogenesis, November 1, 2006; 27(11): 2209 - 2216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson
Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Cheng, K. L. Penney, D. O. Stram, L. Le Marchand, E. Giorgi, C. A. Haiman, L. N. Kolonel, M. Pike, J. Hirschhorn, B. E. Henderson, et al.
Haplotype-Based Association Studies of IGFBP1 and IGFBP3 with Prostate and Breast Cancer Risk: The Multiethnic Cohort.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1993 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Guo, D.-H. Xiong, T.-L. Yang, Y.-F. Guo, R. R. Recker, and H.-W. Deng
Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females
Hum. Mol. Genet., August 15, 2006; 15(16): 2401 - 2408.
[Abstract] [Full Text] [PDF]


Home page
BiostatisticsHome page
R. L. Prentice and L. QI
Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation
Biostat., July 1, 2006; 7(3): 339 - 354.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Sweeney, K. Curtin, M. A. Murtaugh, B. J. Caan, J. D. Potter, and M. L. Slattery
Haplotype analysis of common vitamin d receptor variants and colon and rectal cancers.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 744 - 749.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. Cheng, D. O. Stram, K. L. Penney, M. Pike, L. Le Marchand, L. N. Kolonel, J. Hirschhorn, D. Altshuler, B. E. Henderson, and M. L. Freedman
Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort
J Natl Cancer Inst, January 18, 2006; 98(2): 123 - 134.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. W. Setiawan, I. Cheng, D. O. Stram, K. L. Penney, L. Le Marchand, D. Altshuler, L. N. Kolonel, J. Hirschhorn, B. E. Henderson, and M. L. Freedman
IGF-I Genetic Variation and Breast Cancer: the Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 172 - 174.
[Full Text] [PDF]


Home page
Hum ReprodHome page
C. J. Petry, K. K. Ong, K. F. Michelmore, S. Artigas, D. L. Wingate, A. H. Balen, F. de Zegher, L. Ibanez, and D. B. Dunger
Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women
Hum. Reprod., July 1, 2005; 20(7): 1837 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Han, D. Kang, J. E. Lee, I. A. Park, J.-Y. Choi, K.-M. Lee, J. Y. Bae, S. Kim, E.-S. Shin, J. E. Lee, et al.
A Haplotype Analysis of HER-2 Gene Polymorphisms: Association with Breast Cancer Risk, HER-2 Protein Expression in the Tumor, and Disease Recurrence in Korea
Clin. Cancer Res., July 1, 2005; 11(13): 4775 - 4778.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. M. Dunning, M. Dowsett, C. S. Healey, R. N. Luben, E. Folkerd, P. D. P. Pharoah, D. F. Easton, N. E. D. Bruce, and A. J. Ponder
RESPONSE: Re: Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
J Natl Cancer Inst, January 19, 2005; 97(2): 153 - 154.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. L. Pearce, J. N. Hirschhorn, A. H. Wu, N. P. Burtt, D. O. Stram, S. Young, L. N. Kolonel, B. E. Henderson, D. Altshuler, and M. C. Pike
Clarifying the PROGINS Allele Association in Ovarian and Breast Cancer Risk: A Haplotype-Based Analysis
J Natl Cancer Inst, January 5, 2005; 97(1): 51 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Helisalmi, M Hiltunen, S Vepsalainen, S Iivonen, A Mannermaa, M Lehtovirta, A M Koivisto, I Alafuzoff, and H Soininen
Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients
J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1746 - 1748.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. L. Freedman, K. L. Penney, D. O. Stram, L. Le Marchand, J. N. Hirschhorn, L. N. Kolonel, D. Altshuler, B. E. Henderson, and C. A. Haiman
Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort
Hum. Mol. Genet., October 1, 2004; 13(20): 2431 - 2441.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. M. Dunning, M. Dowsett, C. S. Healey, L. Tee, R. N. Luben, E. Folkerd, K. L. Novik, L. Kelemen, S. Ogata, P. D. P. Pharoah, et al.
Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
J Natl Cancer Inst, June 16, 2004; 96(12): 936 - 945.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.